NO995681L - Fremgangsmåte for å fremstille fluorbiprofen-tabletter - Google Patents

Fremgangsmåte for å fremstille fluorbiprofen-tabletter

Info

Publication number
NO995681L
NO995681L NO995681A NO995681A NO995681L NO 995681 L NO995681 L NO 995681L NO 995681 A NO995681 A NO 995681A NO 995681 A NO995681 A NO 995681A NO 995681 L NO995681 L NO 995681L
Authority
NO
Norway
Prior art keywords
tablets
mixture
fluorobiprofen
preparing
forming
Prior art date
Application number
NO995681A
Other languages
English (en)
Other versions
NO995681D0 (no
Inventor
Andrew Day
Huw Lyn Jones
Carl Simon Smith
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO995681L publication Critical patent/NO995681L/no
Publication of NO995681D0 publication Critical patent/NO995681D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av en farmasøytisk. tablettformulering omfattende trinnene : 1) granulering av en blanding av flurbiprofen og et fyllstoff med en løsning av et bindemiddel i et polart løsningsmiddel for å danne granuler, 2) smelte en lozengedannende blanding, 3) blande granulene med den smeltede lozengedannende blandingen og 4) forme den resulterende blandingen til tabletter hver inneholdende en terapeutisk effektiv mengde av flurbiprofen.
NO995681A 1997-05-22 1999-11-19 Fremgangsmåte for å fremstille fluorbiprofen-tabletter NO995681D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (2)

Publication Number Publication Date
NO995681L true NO995681L (no) 1999-11-19
NO995681D0 NO995681D0 (no) 1999-11-19

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995681A NO995681D0 (no) 1997-05-22 1999-11-19 Fremgangsmåte for å fremstille fluorbiprofen-tabletter

Country Status (31)

Country Link
US (1) US6194003B1 (no)
EP (1) EP0983059B1 (no)
JP (1) JP2001527567A (no)
KR (1) KR20010012739A (no)
CN (1) CN1154480C (no)
AR (1) AR015812A1 (no)
AT (1) ATE245021T1 (no)
AU (1) AU725760B2 (no)
BG (1) BG103881A (no)
BR (1) BR9809651A (no)
CA (1) CA2290830C (no)
CZ (1) CZ290816B6 (no)
DE (1) DE69816440T2 (no)
DK (1) DK0983059T3 (no)
ES (1) ES2202871T3 (no)
GB (1) GB9710521D0 (no)
HU (1) HU224954B1 (no)
ID (1) ID22949A (no)
IL (1) IL132999A0 (no)
IN (1) IN187837B (no)
MY (1) MY118410A (no)
NO (1) NO995681D0 (no)
NZ (1) NZ500664A (no)
PL (1) PL190947B1 (no)
PT (1) PT983059E (no)
RU (1) RU2203046C2 (no)
SK (1) SK283701B6 (no)
TR (1) TR199902725T2 (no)
UA (1) UA53714C2 (no)
WO (1) WO1998052539A1 (no)
ZA (1) ZA984260B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124124B2 (en) 1999-12-09 2012-02-28 Reckitt Benckiser Healthcare (Uk) Limited Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2644400C (en) 2005-02-03 2014-04-08 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
BRPI0809430A2 (pt) * 2007-07-23 2014-09-09 Teikoku Pharma Usa Inc Formulações de dosagem oral, organolepticamente aceitáveis, de um agonista indol do receptor de cerotonina e métodos de utilização das mesmas
US8569375B2 (en) * 2008-08-22 2013-10-29 Reckitt Benckiser Healthcare (Uk) Limited Compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
EP2701681B1 (en) 2011-04-29 2016-10-19 Moberg Pharma AB Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
SK158899A3 (en) 2000-05-16
AU7916598A (en) 1998-12-11
HU224954B1 (en) 2006-04-28
WO1998052539A1 (en) 1998-11-26
ID22949A (id) 1999-12-16
ATE245021T1 (de) 2003-08-15
MY118410A (en) 2004-10-30
DE69816440D1 (de) 2003-08-21
EP0983059B1 (en) 2003-07-16
TR199902725T2 (xx) 2000-02-21
DK0983059T3 (da) 2003-11-03
GB9710521D0 (en) 1997-07-16
HUP0002121A3 (en) 2001-04-28
IL132999A0 (en) 2001-03-19
AU725760B2 (en) 2000-10-19
JP2001527567A (ja) 2001-12-25
KR20010012739A (ko) 2001-02-26
EP0983059A1 (en) 2000-03-08
NO995681D0 (no) 1999-11-19
ZA984260B (en) 1999-02-20
DE69816440T2 (de) 2004-05-13
CA2290830A1 (en) 1998-11-26
CN1255848A (zh) 2000-06-07
BG103881A (bg) 2000-05-31
BR9809651A (pt) 2000-07-11
NZ500664A (en) 2001-01-26
PT983059E (pt) 2003-11-28
AR015812A1 (es) 2001-05-30
RU2203046C2 (ru) 2003-04-27
UA53714C2 (uk) 2003-02-17
PL190947B1 (pl) 2006-02-28
CA2290830C (en) 2006-07-11
ES2202871T3 (es) 2004-04-01
CZ412099A3 (cs) 2000-02-16
CN1154480C (zh) 2004-06-23
US6194003B1 (en) 2001-02-27
SK283701B6 (sk) 2003-12-02
HUP0002121A2 (hu) 2000-12-28
IN187837B (no) 2002-06-29
CZ290816B6 (cs) 2002-10-16
PL336624A1 (en) 2000-07-03

Similar Documents

Publication Publication Date Title
AR015812A1 (es) Proceso para producir una formulacion farmaceutica en pastillas
CA2225286A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
RU98123589A (ru) Композиция для орального введения, способ снижения обжигающего послевкусия композиций пропионовой кислоты
AU7061587A (en) Controlled-release pharmaceutical composition for periodontal diseases
DE2966767D1 (en) Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them
ES8602599A1 (es) Un procedimiento de preparar un derivado de trans-1,2-diaminoxiclohexil-amida.
IE821861L (en) Pharmaceutical compositions
EP0003199A3 (en) Tetrahydropyridinyl indole derivatives and their salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them
IL112957A0 (en) Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them
GEP20033062B (en) Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative
DE3477924D1 (en) Benzenesulphonyl lactams, process for their preparation and their use as active ingredients in pharmaceutical compounds
DK136487A (da) Farmaceutisk praeparat indeholdende ibuprofen og fremgangsmaade til fremstilling deraf
EP0295212A3 (en) Process for preparing a pharmaceutical composition
DE2966706D1 (en) Substituted anthranilic acid amides, process for their preparation, pharmaceutical compositions containing them and their preparation
AU7292794A (en) A method of manufacturing a laxative composition dosage unit and dosage units obtained thereby
PT74937A (en) Process for the preparation of novel analgesic and antiinflammatory compounds and of pharmaceutical compositions containing the same
ES8604731A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina
KR890007745A (ko) 약학조성물 및 그의 제조방법
PT80131A (en) Process for the preparation of pharmaceutical compositions in liquid dosage form suitable for oral administration of 4&#39;-demethylepipodophyllotoxin-9-&lt;4,6-o(r)-ethylidene-beta-d-glucopyranoside&gt;(etoposide)
KR890001559A (ko) 트라피딜을 함유하는 제약 조성물, 그의 제조방법 및 관련된 치료 용도
ES8506717A1 (es) Procedimiento de preparacion de nuevos derivados de 1, 3-dihidro-6-metil-7-hidroxi-furo-(3, 4-c)-piridina
DE69102143D1 (de) Spiramycin enthaltende arzneimittel und verfahren zu deren herstellung.
HU175413B (hu) Sposob poluchenija zamehhennykh proizvodnykh indola i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
GR3034549T3 (en) Anhydrous composition comprising lactulose
HUT34489A (en) Process for preparing 7-oxo-4-thia-1-aza-bicyclo/3,2,0/hept-2-ene derivatives and pharmaceutical compositions containing thereof as active substances

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application